Catalyst Pharma Inc - CPRX - stock price prediction, stock price target, analyst ratings from 7 analysts

Catalyst Pharma Inc has a share price target of US$ 35, revenue growth forecast of 17.6%, and profit growth estimate of 25.3% for FY25, based on top 7 analyst calls.